David Simpson, MD, FAAN

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Abbvie
    Topic:
    Spasticity
    Date added:
    09/12/2026
    Date updated:
    09/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Ipsen
    Topic:
    Spasticity
    Date added:
    09/12/2026
    Date updated:
    09/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Merz
    Date added:
    09/12/2026
    Date updated:
    09/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Abbvie
    Topic:
    Spasticity
    Date added:
    09/12/2026
    Date updated:
    09/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Ipsen
    Topic:
    Spasticity
    Date added:
    09/12/2026
    Date updated:
    09/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Merz
    Topic:
    Spasticity
    Date added:
    09/12/2026
    Date updated:
    09/12/2026
Return to Spasticity and Movement Disorders IMPACT Initiative (IMproving Patient Assessment and Chemodenervation Treatment